Author

A. M. O. Gomes

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

C. H. Dumard· 3 shared J. L. Silva· 3 shared A. C. Oliveira· 2 shared A. Tanuri· 2 shared F. F. Marsili· 2 shared H. L. de Matos Guedes· 2 shared R. G. F. Alvim· 2 shared T. M. L. Souza· 2 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 40 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

C. H. Dumard

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologybioRxivPreprintOct 5, 2021

Immunogenicity of SARS-CoV-2 trimetric spike protein associated to Poly(I:C) plus Alum

J. d. Santos, L. F. Cruz, A. M. d. Fonseca-Martins…·H. L. de Matos Guedes

This study evaluates a vaccine strategy using Alum and Poly(I:C) adjuvants with SARS-CoV-2 spike protein, showing enhanced antibody and T-cell responses and reduced lung inflammation.

DOI 10.1101/2021.10.05.461434

mouseproteomics

𝕏 PostBluesky

ImmunologybioRxivPreprintAug 17, 2020

Potent neutralizing equine antibodies raised against recombinant SARS-CoV-2 spike protein for COVID-19 passive immunization therapy

L. E. R. Cunha, A. A. Stolet, M. A. Strauch…·J. L. Silva

This study produces potent equine antibodies against SARS-CoV-2 spike protein with high neutralizing titers, supporting a clinical trial for passive immunization therapy.

DOI 10.1101/2020.08.17.254375

humanexperimental assay

𝕏 PostBluesky

ImmunologybioRxivPreprintMar 29, 2019

Yellow Fever Vaccine Protects Resistant and Susceptible Mice Against Zika Virus Infection

A. C. Vicente Santos, F. H. Guedes-da-Silva, C. H. Dumard…·J. L. Silva

This study shows that the yellow fever vaccine (17DD) protects both resistant and susceptible mice against Zika virus infection, reducing mortality, viral load, and neurological impairment.

DOI 10.1101/587444

mouseexperimental assay

𝕏 PostBluesky